Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NREF
5301
NexPoint Real Estate Finance
NREF
$319M
| $321K | ﹤0.01% |
21,375
+537
| +3% | +$11K |
|
5302
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
| $321K | ﹤0.01% |
6,560
-325
| -5% | -$16K |
|
5303
Vanguard Total World Bond ETF
BNDW
$1.89B
| $320K | ﹤0.01% |
4,772
+2,331
| +95% | +$163K |
|
5304
Richardson Electronics
RELL
$299M
| $320K | ﹤0.01% |
21,152
+16,517
| +356% | +$261K |
|
5305
Freedom 100 Emerging Markets ETF
FRDM
$3.43B
| $319K | ﹤0.01% |
12,755
+4,425
| +53% | +$124K |
|
5306
RCM Technologies
RCMT
$248M
| $319K | ﹤0.01% |
19,100
-48,689
| -72% | -$843K |
|
5307
BayCom
BCML
$339M
| $318K | ﹤0.01% |
18,116
-78,156
| -81% | -$1.51M |
|
|
ICAD
5308
DELISTED
iCAD Inc
ICAD
| $318K | ﹤0.01% |
151,421
-253,190
| -63% | -$829K |
|
5309
RUM Group Inc
RUM
$3.7B
| $317K | ﹤0.01% |
25,871
-8,848
| -25% | -$97K |
|
5310
NACCO Industries
NC
$322M
| $315K | ﹤0.01% |
6,688
-3,962
| -37% | -$173K |
|
5311
United States Copper Index Fund
CPER
$774M
| $314K | ﹤0.01% |
15,328
+12,245
| +397% | +$258K |
|
|
UXIN
5312
Uxin Ltd
UXIN
$260M
| $314K | ﹤0.01% |
5,233
-925
| -15% | -$62.7K |
|
5313
Nerdy
NRDY
$90.4M
| $313K | ﹤0.01% |
148,290
+128,449
| +647% | +$344K |
|
5314
Global Indemnity Group
GBLI
$395M
| $312K | ﹤0.01% |
14,162
-966
| -6% | -$24.3K |
|
|
STZ.B
5315
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $312K | ﹤0.01% |
1,076
| – | – |
|
|
OCCI
5316
OFS Credit Co
OCCI
$73.7M
| $311K | ﹤0.01% |
35,152
-8,724
| -20% | -$84.7K |
|
|
XFLT
5317
XAI Floating Rate & Alternative Income Trust
XFLT
$294M
| $310K | ﹤0.01% |
10,422
-13,817
| -57% | -$483K |
|
5318
Norwood Financial Corp
NWFL
$376M
| $307K | ﹤0.01% |
11,536
+146
| +1% | +$3.74K |
|
5319
First Trust Developed Markets ex-US Small Cap AlphaDEX Fund
FDTS
$14.2M
| $306K | ﹤0.01% |
9,371
-5,089
| -35% | -$187K |
|
|
CARM
5320
DELISTED
Carisma Therapeutics
CARM
| $305K | ﹤0.01% |
35,904
-13,880
| -28% | -$189K |
|
|
VLDR
5321
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $305K | ﹤0.01% |
323,917
-1,025,270
| -76% | -$1.2M |
|
5322
Build-A-Bear
BBW
$481M
| $304K | ﹤0.01% |
22,771
-1,930
| -8% | -$30.2K |
|
|
JOAN
5323
DELISTED
JOANN, Inc. Common Stock
JOAN
| $303K | ﹤0.01% |
45,692
+11,582
| +34% | +$99.1K |
|
|
LYLT
5324
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $303K | ﹤0.01% |
250,635
-348,822
| -58% | -$906K |
|
5325
Bio-Rad Laboratories Class B
BIO.B
| $302K | ﹤0.01% |
724
| – | – |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.